These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37849755)

  • 1. Complement-activating donor-specific anti-HLA antibodies in solid organ transplantation: systematic review, meta-analysis, and critical appraisal.
    Al-Awadhi S; Raynaud M; Louis K; Bouquegneau A; Taupin JL; Aubert O; Loupy A; Lefaucheur C
    Front Immunol; 2023; 14():1265796. PubMed ID: 37849755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.
    Bouquegneau A; Loheac C; Aubert O; Bouatou Y; Viglietti D; Empana JP; Ulloa C; Murad MH; Legendre C; Glotz D; Jackson AM; Zeevi A; Schaub S; Taupin JL; Reed EF; Friedewald JJ; Tyan DB; Süsal C; Shapiro R; Woodle ES; Hidalgo LG; O'Leary J; Montgomery RA; Kobashigawa J; Jouven X; Jabre P; Lefaucheur C; Loupy A
    PLoS Med; 2018 May; 15(5):e1002572. PubMed ID: 29799874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement-Activating Anti-HLA Antibodies in Kidney Transplantation: Allograft Gene Expression Profiling and Response to Treatment.
    Lefaucheur C; Viglietti D; Hidalgo LG; Ratner LE; Bagnasco SM; Batal I; Aubert O; Orandi BJ; Oppenheimer F; Bestard O; Rigotti P; Reisaeter AV; Kamar N; Lebranchu Y; Duong Van Huyen JP; Bruneval P; Glotz D; Legendre C; Empana JP; Jouven X; Segev DL; Montgomery RA; Zeevi A; Halloran PF; Loupy A
    J Am Soc Nephrol; 2018 Feb; 29(2):620-635. PubMed ID: 29042454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of C1q-binding donor-specific anti-HLA antibodies on the clinical outcomes of patients after renal transplantation: A systematic review and meta-analysis.
    Kang ZY; Liu C; Liu W; Li DH
    Transpl Immunol; 2022 Jun; 72():101566. PubMed ID: 35257893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for an important role of both complement-binding and noncomplement-binding donor-specific antibodies in renal transplantation.
    Viglietti D; Lefaucheur C; Glotz D
    Curr Opin Organ Transplant; 2016 Aug; 21(4):433-40. PubMed ID: 27348472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunological relevance of antibodies in solid organ transplantation.
    Mehra NK; Baranwal AK
    Int J Immunogenet; 2016 Dec; 43(6):351-368. PubMed ID: 27870356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation.
    Musat AI; Pigott CM; Ellis TM; Agni RM; Leverson GE; Powell AJ; Richards KR; D'Alessandro AM; Lucey MR
    Liver Transpl; 2013 Oct; 19(10):1132-41. PubMed ID: 23873778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation.
    Lima ACM; Getz J; do Amaral GB; Loth G; Funke VAM; Nabhan SK; Petterle RR; de Marco R; Gerbase-DeLima M; Pereira NF; Bonfim C; Pasquini R
    Transplant Cell Ther; 2023 Aug; 29(8):493.e1-493.e10. PubMed ID: 37220839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of C1q fixing donor-specific antibodies on renal transplant outcome.
    Baranwal AK; Goswami S; Agarwal SK; Kaur G; Mehra NK
    Scand J Immunol; 2021 Jul; 94(1):e13048. PubMed ID: 33914934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
    Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
    Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-specific antibody characteristics, including persistence and complement-binding capacity, increase risk for chronic lung allograft dysfunction.
    Iasella CJ; Ensor CR; Marrari M; Mangiola M; Xu Q; Nolley E; Moore CA; Morrell MR; Pilewski JM; Sanchez PG; McDyer JF; Zeevi A
    J Heart Lung Transplant; 2020 Dec; 39(12):1417-1425. PubMed ID: 32981841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor-Specific HLA Antibodies: A Review of Data Published in 2016.
    Idica A; Everly MJ
    Clin Transpl; 2016; 32():13-22. PubMed ID: 28564519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-binding anti-HLA antibodies are independent predictors of response to treatment in kidney recipients with antibody-mediated rejection.
    Viglietti D; Bouatou Y; Kheav VD; Aubert O; Suberbielle-Boissel C; Glotz D; Legendre C; Taupin JL; Zeevi A; Loupy A; Lefaucheur C
    Kidney Int; 2018 Oct; 94(4):773-787. PubMed ID: 29801667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-human leukocyte antigen immunization after early allograft nephrectomy.
    Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N
    Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A diagnostic 'C' saw: the ups and downs of C1q testing.
    Gebel HM; Bray RA
    Curr Opin Organ Transplant; 2019 Aug; 24(4):402-410. PubMed ID: 31135562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant donor HLA-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation.
    Smith JD; Ibrahim MW; Newell H; Danskine AJ; Soresi S; Burke MM; Rose ML; Carby M
    J Heart Lung Transplant; 2014 Oct; 33(10):1074-82. PubMed ID: 24954882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor-Specific Antibodies and Primary Graft Failure in Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Xie Y; Parekh J; Tang Z; Wu D; Wu X
    Transplant Cell Ther; 2021 Aug; 27(8):687.e1-687.e7. PubMed ID: 33989833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.